Swiss Caps

Swiss Caps is a prominent Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of soft gelatin capsules for the pharmaceutical and nutraceutical industries. Now a key part of the Aenova Group, the company offers a full suite of services including formulation development, manufacturing, and specialized packaging solutions. Swiss Caps is particularly noted for its expertise in lipid-based drug delivery systems, which enhance the bioavailability of poorly soluble active pharmaceutical ingredients. Their product portfolio includes traditional gelatin capsules as well as innovative vegan alternatives like VegaGels. With multiple GMP-certified facilities across Europe, the company serves a global market, providing high-quality oral dosage forms for both prescription and over-the-counter products.